40 related articles for article (PubMed ID: 20070104)
1. Modulation of the vitamin D receptor by traditional Chinese medicines and bioactive compounds: potential therapeutic applications in VDR-dependent diseases.
Yao M; Oduro PK; Akintibu AM; Yan H
Front Pharmacol; 2024; 15():1298181. PubMed ID: 38318147
[TBL] [Abstract][Full Text] [Related]
2. The Centennial Collection of VDR Ligands: Metabolites, Analogs, Hybrids and Non-Secosteroidal Ligands.
Maestro MA; Seoane S
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432615
[TBL] [Abstract][Full Text] [Related]
3. A multidisciplinary approach disclosing unexplored Aflatoxin B1 roles in severe impairment of vitamin D mechanisms of action.
Persico M; Sessa R; Cesaro E; Dini I; Costanzo P; Ritieni A; Fattorusso C; Grosso M
Cell Biol Toxicol; 2023 Aug; 39(4):1275-1295. PubMed ID: 36066700
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D and Its Synthetic Analogs.
Maestro MA; Molnár F; Carlberg C
J Med Chem; 2019 Aug; 62(15):6854-6875. PubMed ID: 30916559
[TBL] [Abstract][Full Text] [Related]
5. Structural considerations of vitamin D signaling.
Molnár F
Front Physiol; 2014; 5():191. PubMed ID: 24936188
[TBL] [Abstract][Full Text] [Related]
6. Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097.
Huet T; Maehr H; Lee HJ; Uskokovic MR; Suh N; Moras D; Rochel N
Medchemcomm; 2011; 2(5):424-429. PubMed ID: 22180837
[TBL] [Abstract][Full Text] [Related]
7. Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA.
Orlov I; Rochel N; Moras D; Klaholz BP
EMBO J; 2012 Jan; 31(2):291-300. PubMed ID: 22179700
[TBL] [Abstract][Full Text] [Related]
8. Short, enantioselective total syntheses of (-)-8-demethoxyrunanine and (-)-cepharatines A, C, and D.
Chuang KV; Navarro R; Reisman SE
Angew Chem Int Ed Engl; 2011 Sep; 50(40):9447-51. PubMed ID: 21948444
[No Abstract] [Full Text] [Related]
9. 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells.
Slominski AT; Kim TK; Janjetovic Z; Tuckey RC; Bieniek R; Yue J; Li W; Chen J; Nguyen MN; Tang EK; Miller D; Chen TC; Holick M
Am J Physiol Cell Physiol; 2011 Mar; 300(3):C526-41. PubMed ID: 21160030
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of the selective activity of vitamin D analogues.
Carlberg C
J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
[TBL] [Abstract][Full Text] [Related]
11. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
12. Structure-function relationships and crystal structures of the vitamin D receptor bound 2 alpha-methyl-(20S,23S)- and 2 alpha-methyl-(20S,23R)-epoxymethano-1 alpha,25-dihydroxyvitamin D3.
Antony P; Sigüeiro R; Huet T; Sato Y; Ramalanjaona N; Rodrigues LC; Mouriño A; Moras D; Rochel N
J Med Chem; 2010 Feb; 53(3):1159-71. PubMed ID: 20070104
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
[TBL] [Abstract][Full Text] [Related]
14. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
[TBL] [Abstract][Full Text] [Related]
15. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
